(Lebanese) loci were largely protective. The contribution of HLA to T1D must be evaluated with regard to ethnic background.Type 1 (insulin-dependent) diabetes (T1D) is caused by the autoimmune destruction of pancreatic -islet cells (17). Many T1D susceptibility loci have been described and have been mapped into the IDDM1 to IDDM18 loci, of which the HLA region (identified as IDDM1) accounts for more than half of the genetic susceptibility to T1D (2, 16), whereas determination of a strong linkage disequilibrium between the DRB1 and the DQB1 alleles confirmed the contribution of specific HLA DRB1 and DQB1 alleles and DRB1-DQB1 haplotypes to the presence of T1D in many ethnic groups (7,12,16). This was highlighted by the association of DR3-and DR4-containing haplotypes with T1D in Caucasians (8, 10) but not Asians, including Japanese and Koreans (3, 9), in whom different haplotypes contribute to disease susceptibility (9). In view of the geographical/racial heterogeneity of Arabs (1), this study investigated the association of HLA class II (DRB1 and DQB1) haplotypes with T1D in Bahrain (Arabian Peninsula), Lebanon (eastern Mediterranean), and Tunisia (North Africa), in particular with regard to the identification of the specific haplotypes that confer susceptibility to and protection from T1D in each community.Study subjects comprised unrelated Arab subjects from Tunisia (50 patients, 50 controls), Bahrain (126 patients, 126 controls), and Lebanon (78 patients, 111 controls). Non-Arabs (Berbers and Europeans in Tunisia, Armenians in Lebanon, and Iranians in Bahrain) or recently naturalized subjects, identified through personal interviews, were not included. A diagnosis of T1D was made according to clinical features and laboratory findings, and patients with other forms of diabetes (type 2 diabetes, latent autoimmune diabetes in adults, maturity-onset diabetes of the young, etc.) were excluded. The control subjects had normal fasting/random glucose levels and no family history of T1D or other autoimmune diseases. All subjects (patients and controls) were asked to sign a consent form according to the study protocol, and all institutional ethics requirements were met.Total genomic DNA was extracted from EDTA-anticoagulated blood by the phenol-chloroform method. HLA-DRB1 and -DQB1 alleles were analyzed by a PCR sequence-specific priming (PCR-SSP) technique with an SSP2L HLA class II genotyping kit (One Lambda, Thousand Oaks, CA), according to the manufacturer's specifications. The frequencies of the most frequent haplotypes were determined by the maximumlikelihood method with Arlequin (version 2.000) population genetics data analysis software. Data were expressed as P values, odds ratios (ORs), and 95% confidence intervals (CIs) between the patients and the controls in each population.Significant DRB1 and DQB1 allelic differences were seen between Lebanese, Bahraini, and Tunisian T1D patients and controls. Among the Lebanese subjects, DRB1101030ء (Pc Ͻ 0.033), DRB1107031ء (Pc ϭ 0.008), and DQB11020ء (Pc Ͻ 0.001)...